The psychedelics market saw an interesting shift several years ago. Long associated with party drugs, psychedelic substances were now being touted as potentially game changing treatments for a variety of mental health disorders. Driven by changing public opinion, promising scientific research, and loosening restrictions in North America, startups in this space saw a meteoric ...
You don’t need a degree in economics to know we’re having a bad year. With staggeringly high inflation rates, rising interest rates and a stock market that’s had a horrible six months – the worst since 1970 – it’s no surprise that the word recession is being thrown around pretty liberally. Add to that alarmingly ...
The emerging industries space which include psychedelics, plant protein, esports and more, continues to rapidly expand throughout the COVID-19 pandemic, driven by technological advancement and busy capital markets. In our 2021 podcast series “Masters of Disruption,” our host Larry Zeifman spoke with CEOs in numerous emerging industries, discussing their entrepreneurial journeys and issues they ...
This summer, two small but important amendments to the Business Corporations Act (Ontario) came into effect. These amendments eased restrictions on governance so that Ontario businesses can operate more efficiently, ensuring consistency with other Canadian jurisdictions. Effective July 5, 2021, the new amendments also reduced approval thresholds for written shareholder resolutions and led to ...
Recently the use of psychedelics in health care experienced an interesting turning point – not through political gains, but through television. Hulu’s latest hit, Nine Perfect Strangers, depicts the use of psychedelics as a tool in mental health therapy. Now, for anyone who’s seen the show – which follows a wellness retreat gone wrong – it’s ...
Season 2 of our podcast “Micro-dosing with Zeifmans” was a real trip. Pulling knowledge from industry expert guests, we examined the industry as it currently is, and painted a vivid picture of the future as well. Some of the topics we covered include: – Current state of regulatory challenges – Driving force for future ...
Employers in Canada’s emerging industries like cannabis, psychedelics, and agritech are concerned about how upcoming changes to the taxation of stock options will impact their ability to recruit top talent. Traditionally, stock options are among the most enticing incentives used to attract senior talent; particularly the type of executives who are equipped to drive ...
As we’ve spoken about in previous blog posts, the psychedelics industry has been rapidly expanding to become a key component in the treatment of a host of mental illnesses. With multiple parties progressing promising research studies, industry players going public, and regulations across the world relaxing for the industry, the future is looking brighter ...
Innovations in psychedelics are poised to disrupt the pharmaceutical industry, and the Zeifmans Cannabis and Psychedelics Team has been hard at work in the space and is here to demystify these interesting developments. We’re proud to announce our entry into podcasting, having recently launched a brand-new endeavor: “Micro-dosing with Zeifmans”. To listen, look us ...
Research is proving the impressive efficacy of psychedelics in treating conditions like anxiety, depression, and opioid addiction. Psychedelic substances like MDMA, LSD, ketamine, and most notably psilocybin (magic mushrooms) have been gaining traction in recent years as several clinical trials enter Phase II and beyond. And as the cannabis industry has experienced some undeniable ...